Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Extrammune is a proprietary Ayurvedic herbal formulation developed and marketed by Charak Pharma. Available in both tablet and syrup forms, it is designed as a natural immunity enhancer to strengthen the body's defense mechanisms and build resistance against infections. The formulation contains a blend of traditional immunomodulatory, anti-inflammatory, and antioxidant herbs, including Guduchi (*Tinospora cordifolia*), Haridra (*Curcuma longa*), Manjishta (*Rubia cordifolia*), Triphala Guggul, Chitrak (*Plumbago zeylanica*), and Trikatu. Extrammune is used prophylactically to prevent seasonal infections like influenza, or therapeutically as an adjuvant alongside antibiotic therapy for respiratory tract, skin, and soft tissue infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Extrammune.